Author
Listed:
- Katrin Fischer
(Helmholtz Zentrum München and German National Diabetes Center (DZD))
- Anna Fenzl
(Helmholtz Zentrum München and German National Diabetes Center (DZD))
- Dianxin Liu
(Vanderbilt University Medical Center)
- Kenneth A. Dyar
(Helmholtz Zentrum München and German National Diabetes Center (DZD))
- Maximilian Kleinert
(Helmholtz Zentrum München and German National Diabetes Center (DZD)
Technische Universität München
University of Copenhagen)
- Markus Brielmeier
(Research Unit Comparative Medicine, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH)
- Christoffer Clemmensen
(Helmholtz Zentrum München and German National Diabetes Center (DZD)
University of Copenhagen)
- Anna Fedl
(Helmholtz Zentrum München and German National Diabetes Center (DZD))
- Brian Finan
(Helmholtz Zentrum München and German National Diabetes Center (DZD)
Novo Nordisk Research Center)
- Andre Gessner
(University Hospital Regensburg)
- Martin Jastroch
(Helmholtz Zentrum München and German National Diabetes Center (DZD)
The Wenner-Gren Institute, The Arrhenius Laboratories F3, Stockholm University)
- Jianfeng Huang
(Cancer Metabolism and Signaling Networks Program, Sanford Burnham Prebys Medical Discovery Institute)
- Susanne Keipert
(Helmholtz Zentrum München and German National Diabetes Center (DZD)
The Wenner-Gren Institute, The Arrhenius Laboratories F3, Stockholm University)
- Martin Klingenspor
(Chair of Molecular Nutritional Medicine, Technical University of Munich, TUM School of Life Sciences Weihenstephan
EKFZ—Else-Kröner Fresenius Center for Nutritional Medicine, Technical University of Munich)
- Jens C. Brüning
(Max Planck Institute for Metabolism Research
University Hospital Cologne
University of Cologne)
- Manfred Kneilling
(Eberhard Karls University Tübingen
Eberhard Karls University Tübingen)
- Florian C. Maier
(Eberhard Karls University Tübingen)
- Ahmed E. Othman
(Eberhard Karls University Hospital Tübingen)
- Bernd J. Pichler
(Eberhard Karls University Tübingen)
- Ines Pramme-Steinwachs
(Helmholtz Zentrum München and German National Diabetes Center (DZD))
- Stephan Sachs
(Helmholtz Zentrum München and German National Diabetes Center (DZD))
- Angelika Scheideler
(Research Unit Comparative Medicine, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH)
- Wolfgang M. Thaiss
(Eberhard Karls University Tübingen
Eberhard Karls University Hospital Tübingen)
- Henriette Uhlenhaut
(Helmholtz Zentrum München and German National Diabetes Center (DZD))
- Siegfried Ussar
(Helmholtz Zentrum München and German National Diabetes Center (DZD))
- Stephen C. Woods
(University of Cincinnati)
- Julia Zorn
(University of Copenhagen)
- Kerstin Stemmer
(Helmholtz Zentrum München and German National Diabetes Center (DZD)
University of Konstanz)
- Sheila Collins
(Vanderbilt University Medical Center)
- Maria Diaz-Meco
(Cancer Metabolism and Signaling Networks Program, Sanford Burnham Prebys Medical Discovery Institute)
- Jorge Moscat
(Cancer Metabolism and Signaling Networks Program, Sanford Burnham Prebys Medical Discovery Institute)
- Matthias H. Tschöp
(Helmholtz Zentrum München and German National Diabetes Center (DZD)
Technische Universität München)
- Timo D. Müller
(Helmholtz Zentrum München and German National Diabetes Center (DZD)
Eberhard Karls University Hospitals and Clinics)
Abstract
During β-adrenergic stimulation of brown adipose tissue (BAT), p38 phosphorylates the activating transcription factor 2 (ATF2) which then translocates to the nucleus to activate the expression of Ucp1 and Pgc-1α. The mechanisms underlying ATF2 target activation are unknown. Here we demonstrate that p62 (Sqstm1) binds to ATF2 to orchestrate activation of the Ucp1 enhancer and Pgc-1α promoter. P62Δ69-251 mice show reduced expression of Ucp1 and Pgc-1α with impaired ATF2 genomic binding. Modulation of Ucp1 and Pgc-1α expression through p62 regulation of ATF2 signaling is demonstrated in vitro and in vivo in p62Δ69-251 mice, global p62−/− and Ucp1-Cre p62flx/flx mice. BAT dysfunction resulting from p62 deficiency is manifest after birth and obesity subsequently develops despite normal food intake, intestinal nutrient absorption and locomotor activity. In summary, our data identify p62 as a master regulator of BAT function in that it controls the Ucp1 pathway through regulation of ATF2 genomic binding.
Suggested Citation
Katrin Fischer & Anna Fenzl & Dianxin Liu & Kenneth A. Dyar & Maximilian Kleinert & Markus Brielmeier & Christoffer Clemmensen & Anna Fedl & Brian Finan & Andre Gessner & Martin Jastroch & Jianfeng Hu, 2020.
"The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation,"
Nature Communications, Nature, vol. 11(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16230-8
DOI: 10.1038/s41467-020-16230-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16230-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.